atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange… Sep 15, 2021
Awakn Life Sciences Reports Second Quarter 2021 Financial Results and Business Highlights Sep 15, 2021
BevCanna Announces Product Listings and Purchase Orders from British Columbia Liquor Distribution Branch Sep 15, 2021
Perception Neuroscience initiates Phase 2a study of PCN-101 (R-ketamine) for treatment resistant depression Sep 14, 2021
Mindset Pharma Further Validates Lead Candidate, MSP-1014, as a Next Generation Psilocybin Analog through Drug… Sep 14, 2021
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare… Sep 13, 2021
